ZA951798B - Fluorinated vitamin D3 derivative - Google Patents

Fluorinated vitamin D3 derivative

Info

Publication number
ZA951798B
ZA951798B ZA951798A ZA951798A ZA951798B ZA 951798 B ZA951798 B ZA 951798B ZA 951798 A ZA951798 A ZA 951798A ZA 951798 A ZA951798 A ZA 951798A ZA 951798 B ZA951798 B ZA 951798B
Authority
ZA
South Africa
Prior art keywords
derivative
fluorinated vitamin
silyl
fluorinated
vitamin
Prior art date
Application number
ZA951798A
Other languages
English (en)
Inventor
Thomas I Doran
Shian-Jan Shiuey
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA951798B publication Critical patent/ZA951798B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA951798A 1994-03-11 1995-03-03 Fluorinated vitamin D3 derivative ZA951798B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08212453 US5384314B1 (en) 1994-03-11 1994-03-11 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol

Publications (1)

Publication Number Publication Date
ZA951798B true ZA951798B (en) 1996-08-14

Family

ID=22791087

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951798A ZA951798B (en) 1994-03-11 1995-03-03 Fluorinated vitamin D3 derivative

Country Status (22)

Country Link
US (1) US5384314B1 (xx)
EP (1) EP0671387B1 (xx)
JP (1) JP2659345B2 (xx)
KR (1) KR100360732B1 (xx)
CN (1) CN1051227C (xx)
AT (1) ATE165595T1 (xx)
AU (1) AU687972B2 (xx)
BR (1) BR9501035A (xx)
CA (1) CA2141652C (xx)
CZ (1) CZ288793B6 (xx)
DE (1) DE69502223T2 (xx)
DK (1) DK0671387T3 (xx)
ES (1) ES2116634T3 (xx)
FI (1) FI112323B (xx)
HU (1) HU219906B (xx)
IL (1) IL112887A0 (xx)
NO (1) NO307782B1 (xx)
NZ (1) NZ270624A (xx)
PH (1) PH31333A (xx)
PL (1) PL179120B1 (xx)
RU (1) RU2142803C1 (xx)
ZA (1) ZA951798B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US5696103A (en) * 1995-11-17 1997-12-09 Syntex (U.S.A.) Inc. Method for treating osteoporosis
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
US5840718A (en) * 1997-03-06 1998-11-24 Hoffmann-La Roche Inc. 22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
DE69813380T2 (de) * 1997-05-02 2003-12-04 Duphar Int Res Verfahren zur Herstellung von 16-Dehydro Vitamin D Verbindungen
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US5919986A (en) * 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
WO2000051554A2 (en) * 1999-03-05 2000-09-08 Johns Hopkins University Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE10211555A1 (de) * 2002-03-15 2003-10-02 Imtm Inst Fuer Medizintechnolo Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit sebozytärer Hyperproliferation und veränderten Differenzierungszuständen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
JPS6340975A (ja) * 1986-08-05 1988-02-22 Mitsubishi Electric Corp 階調補正方式
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
EP0580968B1 (en) * 1992-05-20 1996-08-28 F. Hoffmann-La Roche Ag Vitamin D3 fluorinated analogs

Also Published As

Publication number Publication date
CA2141652A1 (en) 1995-09-12
RU95103438A (ru) 1997-02-10
DK0671387T3 (da) 1998-10-07
EP0671387B1 (en) 1998-04-29
US5384314B1 (en) 1997-08-05
NO950920L (no) 1995-09-12
CZ63295A3 (en) 1995-11-15
ATE165595T1 (de) 1998-05-15
CN1051227C (zh) 2000-04-12
HU219906B (hu) 2001-09-28
HUT70746A (en) 1995-10-30
HU9500666D0 (en) 1995-04-28
FI951134A0 (fi) 1995-03-10
BR9501035A (pt) 1995-10-31
US5384314A (en) 1995-01-24
JP2659345B2 (ja) 1997-09-30
NZ270624A (en) 1996-06-25
CN1112918A (zh) 1995-12-06
PL179120B1 (pl) 2000-07-31
CA2141652C (en) 2006-05-09
AU1364495A (en) 1995-09-21
AU687972B2 (en) 1998-03-05
CZ288793B6 (cs) 2001-09-12
KR950032046A (ko) 1995-12-20
NO950920D0 (no) 1995-03-10
JPH07258208A (ja) 1995-10-09
NO307782B1 (no) 2000-05-29
FI112323B (fi) 2003-11-28
PH31333A (en) 1998-07-06
EP0671387A1 (en) 1995-09-13
IL112887A0 (en) 1995-06-29
PL307629A1 (en) 1995-09-18
FI951134A (fi) 1995-09-12
ES2116634T3 (es) 1998-07-16
KR100360732B1 (ko) 2003-03-04
DE69502223D1 (de) 1998-06-04
DE69502223T2 (de) 1998-10-29
RU2142803C1 (ru) 1999-12-20

Similar Documents

Publication Publication Date Title
US5384314B1 (en) 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
AU686251B2 (en) Vitamin D3 analogs
WO1998045241A3 (en) Lutein esters having high bioavailability
CA2390295A1 (en) A method for chemoprevention of prostate cancer
CA2157142A1 (en) Treatment of diseases caused by sebaceous gland disorders
AU671445B2 (en) Vitamin D3 fluorinated analogs
YU19997A (sh) Analozi fluorovanog vitamina d3
AU2002308337A1 (en) Compounds and methods for inhibiting axillary malodour
ZA941464B (en) Use of pregnane derivative
CA2267165A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
EP0796843A3 (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
AU7695596A (en) Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat
AU2003207024A1 (en) Spermidine derivatives for the treatment of chronic neurodegenerative diseases
MD940041A (ro) Derivaţi ai acizilor hidroxamici, compoziţie pe baza lor, procedee de combatere a micetelor fitopatogene şi de prevenire a infectării
MY121344A (en) Formulated product